Life Sciences Associate Moderates Boston Bar Association Panel “What’s New in Early Stage Financing?”

Practices: Life Sciences, Private Equity, Health Care Transactions

Life sciences associate Brad Flint (Boston) served as an advisory committee member for the 2019 Boston Bar Association Venture Capital & Private Equity Conference. On April 4, Mr. Flint moderated a conference panel titled “What’s New in Early Stage Financing?” that examined recent trends in financing of early-stage companies, including the use of Simple Agreement for Future Equity (SAFE) instruments, preferred stock financing terms, and financing early-stage companies through strategic and commercial partnerships.

Mr. Flint was joined on the panel by Douglas Eby, CEO of Cambridge Science Corporation; Ben Hron, partner at McCarter & English; and Mike Jabbawy, partner at Morse Barnes-Brown Pendleton.

Cookie Settings